Literature DB >> 8386690

Glycyrrhizic acid in liquorice--evaluation of health hazard.

F C Størmer1, R Reistad, J Alexander.   

Abstract

Literature on case reports, clinical studies and biochemical mechanisms of the sweet-tasting compound glycyrrhizic acid in liquorice was critically reviewed to provide a safety assessment of its presence in liquorice sweets. A high intake of liquorice can cause hypermineralocorticoidism with sodium retention and potassium loss, oedema, increased blood pressure and depression of the renin-angiotensin-aldosterone system. As a consequence, a number of other clinical symptoms have also been observed. Glycyrrhizic acid is hydrolysed in the intestine to the pharmacologically active compound glycyrrhetic acid, which inhibits the enzyme 11 beta-hydroxysteroid dehydrogenase (in the direction of cortisol to cortisone) as well as some other enzymes involved in the metabolism of corticosteroids. Inhibition of 11 beta-hydroxysteroid dehydrogenase leads to increased cortisol levels in the kidneys and in other mineralocorticoid-selective tissues. Since cortisol, which occurs in much larger amounts than aldosterone, binds with the same affinity as aldosterone to the mineralocorticoid receptor, the result is a hypermineralocorticoid effect of cortisol. The inhibitory effect on 11 beta-hydroxysteroid dehydrogenase is reversible; however, the compensatory physiological mechanisms following hypermineralocorticoidism (e.g. depression of the renin-angiotensin system) may last several months. It is not possible, on the basis of existing data, to determine precisely the minimum level of glycyrrhizic acid required to produce the described symptoms. There is apparently a great individual variation in the susceptibility to glycyrrhizic acid. In the most sensitive individuals a regular daily intake of no more than about 100 mg glycyrrhizic acid, which corresponds to 50 g liquorice sweets (assuming a content of 0.2% glycyrrhizic acid), seems to be enough to produce adverse effects. Most individuals who consume 400 mg glycyrrhizic acid daily experience adverse effects. Considering that a regular intake of 100 mg glycyrrhizic acid/day is the lowest-observed-adverse-effect level and using a safety factor of 10, a daily intake of 10 mg glycyrrhizic acid would represent a safe dose for most healthy adults. A daily intake of 1-10 mg glycyrrhizic acid/person has been estimated for several countries. However, an uneven consumption pattern suggests that a considerable number of individuals who consume large amounts of liquorice sweets are exposed to the risk of developing adverse effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386690     DOI: 10.1016/0278-6915(93)90080-i

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  43 in total

1.  Hypokaliemic rhabdomyolysis associated with liquorice ingestion: report of an atypical case.

Authors:  M Barrella; G Lauria; R Quatrale; E Paolino
Journal:  Ital J Neurol Sci       Date:  1997-08

2.  Effect of licorice extract on cell viability, biofilm formation and exotoxin production by Staphylococcus aureus.

Authors:  Yadahalli Shrihari Rohinishree; Pradeep Singh Negi
Journal:  J Food Sci Technol       Date:  2015-12-10       Impact factor: 2.701

Review 3.  The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis.

Authors:  R Penninkilampi; E M Eslick; G D Eslick
Journal:  J Hum Hypertens       Date:  2017-06-29       Impact factor: 3.012

4.  Nutriceuticals in health and disease prevention.

Authors:  Simmi Kharb; Veena Singh
Journal:  Indian J Clin Biochem       Date:  2004-01

5.  A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling.

Authors:  B Ploeger; T Mensinga; A Sips; J Meulenbelt; J DeJongh
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

6.  Effects of 18β-Glycyrrhetinic acid in hTNFtg mice - a model of rheumatoid arthritis.

Authors:  Antonia Puchner; Silvia Hayer; Birgit Niederreiter; Anastasiya Hladik; Stephan Blueml; Michael Bonelli; Clemens Scheinecker; Josef Smolen; Kurt Redlich
Journal:  Wien Klin Wochenschr       Date:  2012-01-03       Impact factor: 1.704

Review 7.  Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern.

Authors:  Haider Rahman; Marina Kim; Galen Leung; Jesse A Green; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

8.  Food-drug interactions.

Authors:  Rabia Bushra; Nousheen Aslam; Arshad Yar Khan
Journal:  Oman Med J       Date:  2011-03

9.  Isoangustone A, a novel licorice compound, inhibits cell proliferation by targeting PI3K, MKK4, and MKK7 in human melanoma.

Authors:  Nu Ry Song; Eunjung Lee; Sanguine Byun; Jong-Eun Kim; Madhusoodanan Mottamal; Jung Han Yoon Park; Soon Sung Lim; Ann M Bode; Hyong Joo Lee; Ki Won Lee; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-08

10.  Doing what comes naturally.

Authors:  Mark C Henderson; Gurpreet Dhaliwal; Stephen R Jones; Charles Culbertson; Judith L Bowen
Journal:  J Gen Intern Med       Date:  2010-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.